[go: up one dir, main page]

AU2593701A - Method for preventing an anaphylactic reaction - Google Patents

Method for preventing an anaphylactic reaction

Info

Publication number
AU2593701A
AU2593701A AU25937/01A AU2593701A AU2593701A AU 2593701 A AU2593701 A AU 2593701A AU 25937/01 A AU25937/01 A AU 25937/01A AU 2593701 A AU2593701 A AU 2593701A AU 2593701 A AU2593701 A AU 2593701A
Authority
AU
Australia
Prior art keywords
preventing
anaphylactic reaction
anaphylactic
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25937/01A
Other languages
English (en)
Inventor
Anthony A. Horner
Eyal Raz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
University of California Berkeley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California, University of California Berkeley filed Critical University of California
Publication of AU2593701A publication Critical patent/AU2593701A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6025—Nucleotides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU25937/01A 1999-12-21 2000-12-20 Method for preventing an anaphylactic reaction Abandoned AU2593701A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17183099P 1999-12-21 1999-12-21
US60171830 1999-12-21
PCT/US2000/035064 WO2001045750A1 (fr) 1999-12-21 2000-12-20 Methode de prevention d"une reaction anaphylactique

Publications (1)

Publication Number Publication Date
AU2593701A true AU2593701A (en) 2001-07-03

Family

ID=22625306

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25937/01A Abandoned AU2593701A (en) 1999-12-21 2000-12-20 Method for preventing an anaphylactic reaction

Country Status (2)

Country Link
AU (1) AU2593701A (fr)
WO (1) WO2001045750A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7935675B1 (en) 1994-07-15 2011-05-03 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
DE69932717T2 (de) 1998-05-22 2007-08-09 Ottawa Health Research Institute, Ottawa Methoden und produkte zur induzierung mukosaler immunität
NZ513935A (en) 1999-02-17 2004-02-27 Csl Ltd Immunogenic complexes and methods relating thereto
US7585847B2 (en) 2000-02-03 2009-09-08 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for the treatment of asthma and allergy
KR100985457B1 (ko) 2001-06-21 2010-10-06 다이나박스 테크놀로지 코퍼레이션 키메라 면역조절 화합물 및 그것들의 사용 방법
US20030133988A1 (en) 2001-08-07 2003-07-17 Fearon Karen L. Immunomodulatory compositions, formulations, and methods for use thereof
WO2003015711A2 (fr) 2001-08-17 2003-02-27 Coley Pharmaceutical Group, Inc. Oligonucleotides immunostimulateurs a motif combine possedant une activite accrue
ES2734652T3 (es) 2002-04-04 2019-12-11 Zoetis Belgium S A Oligorribonucleótidos inmunoestimulantes que contienen G y U
US7576066B2 (en) 2002-07-03 2009-08-18 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US7569553B2 (en) 2002-07-03 2009-08-04 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US7807803B2 (en) 2002-07-03 2010-10-05 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US20040053880A1 (en) 2002-07-03 2004-03-18 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US7605138B2 (en) 2002-07-03 2009-10-20 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
BR0315810A (pt) 2002-10-29 2005-09-13 Coley Pharmaceutical Group Ltd Uso de oligonucleotìdeos cpg no tratamento de infecção por vìrus da hepatite c
KR101178816B1 (ko) 2002-12-23 2012-09-07 다이나박스 테크놀로지 코퍼레이션 면역자극성 서열 올리고뉴클레오타이드 및 이의 이용방법
US8158768B2 (en) 2002-12-23 2012-04-17 Dynavax Technologies Corporation Immunostimulatory sequence oligonucleotides and methods of using the same
EP1928492B1 (fr) * 2005-09-01 2011-02-23 Celgene Corporation Utilisations immunologiques de composes immunomodulateurs pour vaccins et traitement anti-infectieux de maladies
KR20080072934A (ko) 2005-11-25 2008-08-07 콜리 파마슈티칼 게엠베하 면역자극성 올리고리보뉴클레오티드
NZ575437A (en) 2006-09-27 2012-02-24 Coley Pharm Gmbh Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3468773B2 (ja) * 1994-07-15 2003-11-17 ザ ユニバーシティ オブ アイオワ リサーチ ファウンデーション 免疫調節オリゴヌクレオチド

Also Published As

Publication number Publication date
WO2001045750A1 (fr) 2001-06-28

Similar Documents

Publication Publication Date Title
AU2593701A (en) Method for preventing an anaphylactic reaction
AU2803800A (en) An authentication method
AU1882901A (en) Pointing method
EP0939531A3 (fr) Méthode de formation d'une icône
AU5304299A (en) Method for modifying chromosomes
AU6940300A (en) Self-spotting apparatus for free-weights
AU7871800A (en) Method for remote access of vehicle components
AU1854901A (en) Novel method
AUPQ278799A0 (en) An access control method
AU6053600A (en) Encapsulation method for maintaining biodecontamination activity
AU2258399A (en) Method for irradiating an item
AU6645398A (en) Method for protecting bytecode
AU2037101A (en) Method for immobilisation
AU3583000A (en) Method for direct steelmaking
AU5650401A (en) Method for enhancing cognitive function
AU2224001A (en) Hologram forming method
AU6997800A (en) Method for product assurance
AU3439301A (en) Method for preventing diarrhea
AU2550400A (en) Method for maintaining an inventory
AU3656900A (en) Granulation method
AU5272800A (en) Method for applying bsr elastomer
AU1141501A (en) Method for producing hydroxymethylpyridines
AU1283001A (en) Method for producing alkylhalogenosilanes
AU4585100A (en) Method
AU5552200A (en) Method

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase